Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: Possible beneficial effects on peritoneal membrane and peritonitis rates

International Urology and Nephrology

Volumn 41, Issue 2, 2009, Pages 431-434

  Tapiawala, Shruti N ^a   Bargman, Joanne M ^a   Oreopoulos, Dimitrios G ^a   Simons, Martin ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Angiogenesis; Metastaticrenal cell carcinoma; Peritoneal dialysis; Peritoneal membrane thickness; Peritonitis; Tyrosine kinase inhibitors

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; ICODEXTRIN; INTERFERON; SUNITINIB; THYROID HORMONE;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW METASTASIS; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; HEMODIALYSIS PATIENT; HEMOPTYSIS; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INTESTINE CARCINOMA; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY FAILURE; LONG TERM CARE; LUNG METASTASIS; LYMPHADENOPATHY; METASTASIS; METASTASIS POTENTIAL; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND TUMOR; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PHOTOTHERAPY; SEIZURE; SKIN CYST; SPINAL CORD METASTASIS; TREATMENT DURATION; ULTRAFILTRATION; WALKING DIFFICULTY;

ABDOMINAL NEOPLASMS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INDOLES; KIDNEY NEOPLASMS; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; PROTEIN-TYROSINE KINASES; PYRROLES;

EID: 67349159450     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9545-x     Document Type: Article

References (15)

1. Combet S, Van Landschoot M, Moulin P (2000) Vascular proliferation and enhanced expression of endothelial nitric oxide synthetase in human peritoneum exposed to long term peritoneal dialysis. J Am Soc Nephrol 11:717-728
2. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356(2):115-124. doi: 10.1056/NEJMoa065044
3. Rock EP, Goodman V, Jiang J, Mahjoor K, Verbois SL, Morse D, Dagher R, Justice R, Padzur R (2007) Food and drug administration drug approval summary: Sunitinib Maleate for treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma. Oncologist 12:107-113. doi: 10.1634/theoncologist.12-1-107
4. Chow LQ, Eckhardt SG (2007) Sunitinib: From rational design to clinical efficacy. J Clin Oncol 7(25):884-896. doi: 10.1200/JCO.2006.06.3602
5. Yoko Y, Masanobu M, Katsushige A, Tomoya N, Akira F, Yoshei M, Takashi H, Yoshiyuki O, Takehiko K, Shigeru (2004) TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. Kidney Int (66):1677-1685
6. Honda K, Nitta K, Horita S (1996) Morphologic changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72:171-176. doi: 10.1159/000188837
7. Williams JD, Craig KJ, Topley N (2002) Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479
8. Zweers MM, Struijk DG, Smit W (2001) Vascular endothelial growth factor in peritoneal dialysis: A longitudinal follow up. J Lab Clin Med 137:125-132. doi: 10.1067/mlc.2001.112235
9. Zweers MM DE, Waart DR, Smit W (1999) Growth factors VEGEF and TGF-beta 1 in peritoneal dialysis. J Lab Clin Med 134:124-132. doi: 10.1016/ S0022-2143(99)90116-6
10. Duman S, Ozbek SS, Gunay ES, Bozkurt D, Asci G, Sipahi S, Kircelli F, Ertilav M, Ozkahya M, Ok E (2007) What does peritoneal thickness in peritoneal dialysis patients tell us? Adv Perit Dial 23:28-33
11. Ahmad M, Shah H, Pliakogiannis T, Oreopoulos DG (2007) Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions. Int Urol Nephrol 39:299-312. doi: 10.1007/ s11255-006-9064-y
12. Krishnan A, Oreopoulos DG (2007) Peritoneal dialysis in congestive heart failure. Adv Perit Dial 23:82-89
13. Vas S (1983) Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int 23:83-92. doi: 10.1038/ki.1983.15
14. Stevenson JA, Jurado JL, Belli DD, Horton SJ (2006) Recurring enteric peritonitis associated with non-perforating colon carcinoma. Clin Nephrol 65(6):453-456
15. Schweinburg FB, Seligman AM, Fine J (1950) Transmural migration of intestinal bacteria. N Engl J Med 242:747-751